Arrow Financial’s AstraZeneca AZN Stock Holding History

Arrow Financial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-144	Closed	-$10K	–	346
2015 Q1	$10K	Buy	+144	New	+$10K	﹤0.01%	280

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Arrow Financial's AZN Position: Q2 2015 in Review

Arrow Financial sold out of AstraZeneca (AZN) in Q2 2015, closing a stake of 144 shares — an estimated $10K sold.

Arrow Financial first reported a position in AZN in Q1 2015 and held it in 1 quarter. The position peaked at $10K in Q1 2015. 376 funds tracked by Wall St. Rank hold AZN as of Q2 2015.

Arrow Financial reported no remaining AstraZeneca position as of Q2 2015 after selling out during the quarter.
Arrow Financial sold 144 AstraZeneca shares in Q2 2015, an estimated $10K.
Arrow Financial first reported a position in AstraZeneca in Q1 2015 and held it in 1 quarter.
Arrow Financial's AstraZeneca position peaked at $10K in Q1 2015.
376 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2015.

Based on Arrow Financial's 13F filing for Q2 2015, filed 28 Jul 2015.